DADA NEXUS LTD-ADR (DADA) Fundamental Analysis & Valuation

NASDAQ:DADA • US23344D1081

Current stock price

1.96 USD
-0.03 (-1.26%)
At close:
1.93 USD
-0.03 (-1.53%)
After Hours:

This DADA fundamental analysis includes valuation metrics, fair value assessment, financial health analysis, profitability trends, growth metrics and dividend sustainability analysis.

1

1. DADA Profitability Analysis

1.1 Basic Checks

  • In the past year DADA has reported negative net income.
  • DADA had a negative operating cash flow in the past year.
  • DADA had negative earnings in each of the past 5 years.
  • DADA had a negative operating cash flow in each of the past 5 years.
DADA Yearly Net Income VS EBIT VS OCF VS FCFDADA Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2017 2018 2019 2020 2021 2022 2023 2024 -500M -1B -1.5B -2B -2.5B

1.2 Ratios

  • The Return On Assets of DADA (-39.11%) is worse than 90.24% of its industry peers.
  • DADA has a worse Return On Equity (-56.52%) than 80.49% of its industry peers.
Industry RankSector Rank
ROA -39.11%
ROE -56.52%
ROIC N/A
ROA(3y)-29.05%
ROA(5y)-31.15%
ROE(3y)-40.15%
ROE(5y)-43.05%
ROIC(3y)N/A
ROIC(5y)N/A
DADA Yearly ROA, ROE, ROICDADA Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2017 2018 2019 2020 2021 2022 2023 2024 -20 -40 -60

1.3 Margins

  • Looking at the Gross Margin, with a value of 25.27%, DADA is in the better half of the industry, outperforming 60.98% of the companies in the same industry.
  • In the last couple of years the Gross Margin of DADA has grown nicely.
  • DADA does not have Profit Margin and Operating Margin available, so we won't be analyzing them here.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM 25.27%
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y0.16%
GM growth 5Y25.28%
DADA Yearly Profit, Operating, Gross MarginsDADA Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2017 2018 2019 2020 2021 2022 2023 2024 0 -50 -100

More info and screens

ROAROEROICOperating and Profit MarginShow most profitable peers

7

2. DADA Health Analysis

2.1 Basic Checks

  • DADA does not have a ROIC to compare to the WACC, probably because it is not profitable.
  • DADA has less shares outstanding than it did 1 year ago.
  • DADA has more shares outstanding than it did 5 years ago.
  • There is no outstanding debt for DADA. This means it has a Debt/Equity and Debt/FCF ratio of 0 and it is amongst the best of the sector and industry.
DADA Yearly Shares OutstandingDADA Yearly Shares OutstandingYearly Shares Outstanding 2017 2018 2019 2020 2021 2022 2023 2024 50M 100M 150M 200M 250M
DADA Yearly Total Debt VS Total AssetsDADA Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2017 2018 2019 2020 2021 2022 2023 2024 2B 4B 6B 8B

2.2 Solvency

  • DADA has an Altman-Z score of -1.45. This is a bad value and indicates that DADA is not financially healthy and even has some risk of bankruptcy.
  • Looking at the Altman-Z score, with a value of -1.45, DADA is doing worse than 92.68% of the companies in the same industry.
  • There is no outstanding debt for DADA. This means it has a Debt/Equity and Debt/FCF ratio of 0 and it is amongst the best of the sector and industry.
Industry RankSector Rank
Debt/Equity 0
Debt/FCF N/A
Altman-Z -1.45
ROIC/WACCN/A
WACC7.54%
DADA Yearly LT Debt VS Equity VS FCFDADA Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2017 2018 2019 2020 2021 2022 2023 2024 0 2B -2B 4B 6B

2.3 Liquidity

  • DADA has a Current Ratio of 3.27. This indicates that DADA is financially healthy and has no problem in meeting its short term obligations.
  • DADA's Current ratio of 3.27 is amongst the best of the industry. DADA outperforms 97.56% of its industry peers.
  • A Quick Ratio of 3.27 indicates that DADA has no problem at all paying its short term obligations.
  • DADA's Quick ratio of 3.27 is amongst the best of the industry. DADA outperforms 97.56% of its industry peers.
Industry RankSector Rank
Current Ratio 3.27
Quick Ratio 3.27
DADA Yearly Current Assets VS Current LiabilitesDADA Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2017 2018 2019 2020 2021 2022 2023 2024 2B 4B 6B

More info and screens

WACCDebt/EquityHow to determine the health of a companyAltman-Z scoreShow peers with great health

5

3. DADA Growth Analysis

3.1 Past

  • DADA shows a strong negative growth in Earnings Per Share. In the last year the EPS decreased by -13.10%.
  • Looking at the last year, DADA shows a decrease in Revenue. The Revenue has decreased by -5.74% in the last year.
  • The Revenue has been growing by 25.54% on average over the past years. This is a very strong growth!
EPS 1Y (TTM)-13.1%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%80%
Revenue 1Y (TTM)-5.74%
Revenue growth 3Y12.07%
Revenue growth 5Y25.54%
Sales Q2Q%-11.61%

3.2 Future

  • The Earnings Per Share is expected to grow by 21.89% on average over the next years. This is a very strong growth
  • The Revenue is expected to grow by 15.26% on average over the next years. This is quite good.
EPS Next Y-120.46%
EPS Next 2Y20.69%
EPS Next 3Y55.87%
EPS Next 5Y21.89%
Revenue Next Year12.27%
Revenue Next 2Y12.78%
Revenue Next 3Y15.13%
Revenue Next 5Y15.26%

3.3 Evolution

  • The estimated forward Revenue growth is still strong, although it is decreasing when compared to the stronger growth in the past years.
DADA Yearly Revenue VS EstimatesDADA Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 2031 2032 5B 10B 15B 20B 25B
DADA Yearly EPS VS EstimatesDADA Yearly EPS VS EstimatesYearly EPS VS Estimates 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 2031 0 -2 -4 -6 -8

More info and screens

Find the best growth stocksShow best growing peers

1

4. DADA Valuation Analysis

4.1 Price/Earnings Ratio

  • DADA reported negative earnings for the last year, which makes the Price/Earnings Ratio negative.
  • Besides the negative Price/Earnings Ratio, also the Forward Price/Earnings Ratio is negative for DADA. No positive earnings are expected for the next year.
Industry RankSector Rank
PE N/A
Fwd PE N/A
DADA Price Earnings VS Forward Price EarningsDADA Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 10 -10 20

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA N/A
DADA Per share dataDADA EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 1 2 3 4 5

4.3 Compensation for Growth

  • A more expensive valuation may be justified as DADA's earnings are expected to grow with 55.87% in the coming years.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y20.69%
EPS Next 3Y55.87%

More info and screens

Price/EarningsPrice/FCFFCF per shareEV/EBITDAPEG RATIOShow best valued peers

0

5. DADA Dividend Analysis

5.1 Amount

  • No dividends for DADA!.
Industry RankSector Rank
Dividend Yield N/A

More info and screens

Find the best dividend stocksShow peers with best dividend

DADA Fundamentals: All Metrics, Ratios and Statistics

DADA NEXUS LTD-ADR

NASDAQ:DADA (6/16/2025, 8:00:01 PM)

After market: 1.93 -0.03 (-1.53%)

1.96

-0.03 (-1.26%)

Chartmill FA Rating
GICS SectorConsumer Staples
GICS IndustryGroupConsumer Staples Distribution & Retail
GICS IndustryConsumer Staples Distribution & Retail
Earnings (Last)05-13
Earnings (Next)08-18
Inst Owners20.11%
Inst Owner Change0%
Ins OwnersN/A
Ins Owner ChangeN/A
Market Cap506.16M
Revenue(TTM)9.66B
Net Income(TTM)-2.04B
Analysts78
Price Target1.76 (-10.2%)
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)2
Avg EPS beat(2)95.04%
Min EPS beat(2)92.42%
Max EPS beat(2)97.65%
EPS beat(4)3
Avg EPS beat(4)56.84%
Min EPS beat(4)-43.76%
Max EPS beat(4)97.65%
EPS beat(8)5
Avg EPS beat(8)33.85%
EPS beat(12)8
Avg EPS beat(12)23.76%
EPS beat(16)11
Avg EPS beat(16)19.11%
Revenue beat(2)1
Avg Revenue beat(2)0.03%
Min Revenue beat(2)-0.63%
Max Revenue beat(2)0.68%
Revenue beat(4)2
Avg Revenue beat(4)-1.46%
Min Revenue beat(4)-6.42%
Max Revenue beat(4)0.68%
Revenue beat(8)2
Avg Revenue beat(8)-3.02%
Revenue beat(12)2
Avg Revenue beat(12)-2.42%
Revenue beat(16)5
Avg Revenue beat(16)-1.02%
PT rev (1m)-6.76%
PT rev (3m)-58.15%
EPS NQ rev (1m)0%
EPS NQ rev (3m)25.28%
EPS NY rev (1m)0%
EPS NY rev (3m)-4.76%
Revenue NQ rev (1m)0%
Revenue NQ rev (3m)0%
Revenue NY rev (1m)0%
Revenue NY rev (3m)1.45%
Valuation
Industry RankSector Rank
PE N/A
Fwd PE N/A
P/S 0.38
P/FCF N/A
P/OCF N/A
P/B 1.01
P/tB 1.01
EV/EBITDA N/A
EPS(TTM)-0.13
EYN/A
EPS(NY)-0.29
Fwd EYN/A
FCF(TTM)-0.57
FCFYN/A
OCF(TTM)-0.57
OCFYN/A
SpS5.22
BVpS1.95
TBVpS1.95
PEG (NY)N/A
PEG (5Y)N/A
Graham NumberN/A
Profitability
Industry RankSector Rank
ROA -39.11%
ROE -56.52%
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM 25.27%
FCFM N/A
ROA(3y)-29.05%
ROA(5y)-31.15%
ROE(3y)-40.15%
ROE(5y)-43.05%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexgc growth 3YN/A
ROICexgc growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y0.16%
GM growth 5Y25.28%
F-Score5
Asset Turnover1.85
Health
Industry RankSector Rank
Debt/Equity 0
Debt/FCF N/A
Debt/EBITDA N/A
Cap/Depr 1.23%
Cap/Sales 0.06%
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 3.27
Quick Ratio 3.27
Altman-Z -1.45
F-Score5
WACC7.54%
ROIC/WACCN/A
Cap/Depr(3y)1.13%
Cap/Depr(5y)4.8%
Cap/Sales(3y)0.06%
Cap/Sales(5y)0.17%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-13.1%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%80%
EPS Next Y-120.46%
EPS Next 2Y20.69%
EPS Next 3Y55.87%
EPS Next 5Y21.89%
Revenue 1Y (TTM)-5.74%
Revenue growth 3Y12.07%
Revenue growth 5Y25.54%
Sales Q2Q%-11.61%
Revenue Next Year12.27%
Revenue Next 2Y12.78%
Revenue Next 3Y15.13%
Revenue Next 5Y15.26%
EBIT growth 1Y4.36%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next Year49.17%
EBIT Next 3Y22.76%
EBIT Next 5Y19.94%
FCF growth 1Y-173.76%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y-177.39%
OCF growth 3YN/A
OCF growth 5YN/A

DADA NEXUS LTD-ADR / DADA Fundamental Analysis FAQ

What is the fundamental rating for DADA stock?

ChartMill assigns a fundamental rating of 4 / 10 to DADA.


What is the valuation status for DADA stock?

ChartMill assigns a valuation rating of 1 / 10 to DADA NEXUS LTD-ADR (DADA). This can be considered as Overvalued.


What is the profitability of DADA stock?

DADA NEXUS LTD-ADR (DADA) has a profitability rating of 1 / 10.


What is the financial health of DADA NEXUS LTD-ADR (DADA) stock?

The financial health rating of DADA NEXUS LTD-ADR (DADA) is 7 / 10.